ANGIONICHE: A biomaterial-guided morphogenesis strategy for mobile neovascularisation therapy using angiogenic microniches (Q2906430): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 85.0 percentage) |
(Changed an Item: Import item from Portugal) |
||||||||||
Property / budget | Property / budget | ||||||||||
| 208,554.8 Euro
| ||||||||||
Property / EU contribution | Property / EU contribution | ||||||||||
| 177,271.58 Euro
| ||||||||||
Property / priority axis | |||||||||||
Property / priority axis: Strengthening research, technological development and innovation (OT1) / rank | |||||||||||
Normal rank | |||||||||||
Property / co-financing rate | |||||||||||
85.0 percent
| |||||||||||
Property / co-financing rate: 85.0 percent / rank | |||||||||||
Normal rank |
Revision as of 01:42, 5 November 2022
Project Q2906430 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | ANGIONICHE: A biomaterial-guided morphogenesis strategy for mobile neovascularisation therapy using angiogenic microniches |
Project Q2906430 in Portugal |
Statements
177,271.58 Euro
0 references
208,554.8 Euro
0 references
85.0 percent
0 references
1 March 2019
0 references
28 February 2022
0 references
INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA
0 references
Q2993187 (Deleted Item)
0 references
Porto
0 references
Identifiers
POCI-01-0145-FEDER-028744
0 references